<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="marinedrugs-16-00256-t001" orientation="portrait" position="float" class="table-wrap">
 <object-id pub-id-type="pii" class="object-id">marinedrugs-16-00256-t001_Table 1</object-id>
 <label class="label">Table 1</label>
 <caption class="caption">
  <p class="p">The fatty acids existing in fish oils for attenuating cutaneous photoaging.</p>
 </caption>
 <table frame="hsides" rules="groups" class="table">
  <thead class="thead">
   <tr class="tr">
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Composition</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Experimental Model</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">UV Type</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Benefit</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Reference</th>
   </tr>
  </thead>
  <tbody class="tbody">
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DHA and EPA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Keratinocytes and skin fibroblasts</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UV 270–400 nm, 25–100 mJ/cm
     <sup class="sup">2</sup>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced IL-8</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Storey et al. [
     <xref rid="B43-marinedrugs-16-00256" ref-type="bibr" class="xref">43</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DHA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Keratinocytes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UV 290–400 nm, 10–60 mJ/cm
     <sup class="sup">2</sup>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reverted cell resistance to UV-induced apoptosis</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Serini et al. [
     <xref rid="B44-marinedrugs-16-00256" ref-type="bibr" class="xref">44</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">EPA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Skin fibroblasts</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UV 275–380 nm, 25–75 mJ/cm
     <sup class="sup">2</sup>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced MMP-1, ERK, and JNK</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kim et al. [
     <xref rid="B46-marinedrugs-16-00256" ref-type="bibr" class="xref">46</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">EPA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">BALB/c mouse with ear edema</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UVB, 500 mJ/cm
     <sup class="sup">2</sup>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Suppressed ear edema by oral EPA administration</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Danno et al. [
     <xref rid="B47-marinedrugs-16-00256" ref-type="bibr" class="xref">47</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DHA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Hairless mouse with skin inflammation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UVB 312 nm, 180 mJ/cm
     <sup class="sup">2</sup>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Decreased COX-2 and NOX-4 by blocking MSK1</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Rahman et al. [
     <xref rid="B48-marinedrugs-16-00256" ref-type="bibr" class="xref">48</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DHA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Hairless mouse with skin inflammation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UVB 312 nm, 180 mJ/cm
     <sup class="sup">2</sup>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Elevated Nrf2 activation and upregulation of cytoprotective genes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Yum et al. [
     <xref rid="B50-marinedrugs-16-00256" ref-type="bibr" class="xref">50</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Fish oil rich of DHA and EPA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UVB with a filter to eliminate wavelengths &lt;295 nm</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Increased minimal erythema dose and decreased serum triglyceride</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Orengo et al. [
     <xref rid="B51-marinedrugs-16-00256" ref-type="bibr" class="xref">51</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Fish oil rich in DHA and EPA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UV 270–400 nm</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Increased minimal erythema dose and decreased PGE2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Rhodes et al. [
     <xref rid="B52-marinedrugs-16-00256" ref-type="bibr" class="xref">52</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Fish oils from mackerel, sardine, and horse mackerel</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Broadband UVB, doubled MED</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Inhibited UVB-induced erythema</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Puglia et al., [
     <xref rid="B53-marinedrugs-16-00256" ref-type="bibr" class="xref">53</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Ethyl esters of EPA and oleic acid</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UV 270–400 nm</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Increased minimal erythema dose and decreased PGE2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Shahbakhti et al. [
     <xref rid="B54-marinedrugs-16-00256" ref-type="bibr" class="xref">54</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">EPA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UV 270–400 nm, 4 × MED</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">No function on Langerhans cell migration and PGD2 expression</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Pilkington et al. [
     <xref rid="B56-marinedrugs-16-00256" ref-type="bibr" class="xref">56</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">EPA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UV 285–350 nm</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Decreased epidermal thickness, procollagen, COX-2, and MMPs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kim et al. [
     <xref rid="B57-marinedrugs-16-00256" ref-type="bibr" class="xref">57</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">LA and ALA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Hairless mouse</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UVB at 312.5 nm, 3.6 × MED</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Lowered erythema score and PGE2 in skin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Takemura et al. [
     <xref rid="B58-marinedrugs-16-00256" ref-type="bibr" class="xref">58</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Conjugated LA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Keratinocytes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UV 270–400 nm, 25–100 mJ/cm
     <sup class="sup">2</sup>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced IL-8 and PGE2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Storey et al. [
     <xref rid="B61-marinedrugs-16-00256" ref-type="bibr" class="xref">61</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot class="table-wrap-foot">
  <fn class="fn">
   <p class="p">COX-2, cyclooxygenase-2; ERK, extracellular-signal-regulated kinase; JNK, Jun-N-terminal kinase; LA, linoleic acid; MED, minimal erythema dose; MMP, metalloproteinases; MSK1, stress-activated kinase-1; NOX-4, nicotinamide adenine dinucleotide phosphate (NADPH): oxidase-4; PGD2, prostaglandin D2; PGE2, prostaglandin E2.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
